TWD
LRMR icon

True Wealth Design’s Larimar Therapeutics LRMR Stock Holding History

True Wealth Design’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.73K Buy
1,550
+1,006
+185% +$3.99K ﹤0.01% 1352
2026
Q1 		$2.45K Hold
544
– – ﹤0.01% 1459
2025
Q4 		$2.07K Buy
544
+8
+1% +$31 ﹤0.01% 1438
2025
Q3 		$1.73K Hold
536
– – ﹤0.01% 1518
2025
Q2 		$1.55K Buy
536
+226
+73% +$523 ﹤0.01% 1282
2025
Q1 		$667 Buy
+310
New +$980 ﹤0.01% 1438

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

True Wealth Design's LRMR Position: Q2 2026 in Review

True Wealth Design increased its Larimar Therapeutics (LRMR) stake by 185% in Q2 2026, buying an estimated $3.99K and bringing the position to 1,550 shares worth $4.73K. The position accounts for ﹤0.01% of the portfolio, ranked #1352.

True Wealth Design first reported a position in LRMR in Q1 2025 and has held it in 6 quarters since. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • True Wealth Design held 1,550 shares of Larimar Therapeutics worth $4.73K as of Q2 2026.
  • True Wealth Design bought 1,006 Larimar Therapeutics shares in Q2 2026, an estimated $3.99K.
  • Larimar Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1352 holding.
  • True Wealth Design first reported a position in Larimar Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.